Enterococcal infections have become one of the most challenging nosocomial problems. Tedizolid, the second oxazolidinone, is 4-fold to 8-fold more potent in vivo and in vitro than linezolid against enterococci. However, the characteristics of tedizolid related to enterococci isolates in China remain elusive. The aim of this study was to evaluate in vitro activity of tedizolid against enterococcal isolates from patients with infections at a teaching hospital in China and to investigate the correlations between in vitro tedizolid activity against enterococci and the distribution of multilocus sequence types (MLST), resistance genes and virulence factors. A total of 289 non-duplicate Enterococcus faecalis strains and 68 E. faecium strains were isolated. Tedizolid inhibited 95.24% of all enterococcal isolates with an MIC ≤ 0.5μg/ml. Seventeen E. faecalis strains had an MIC > 0.5 μg/ml, and all E. faecium were inhibited at MIC ≤ 0.5 μg/ml. The proportion of tedizolid non-susceptible E. faecalis strains with optrA genes was higher than that among tedizolid-susceptible strains. Tedizolid exhibited good in vitro activity against all E. faecium strains, including multidrug-resistant E. faecium carrying tet(M), tet(L),
INTRODUCTION
Enterococcal infections have become one of the most challenging nosocomial infections. Linezolid is an important oxazolidinone antibiotic that was approved for clinical use in 2000 and has shown great potency against most Gram-positive organisms, especially vancomycin-resistant enterococci (VRE). Shortly after the introduction of linezolid into clinical practice, reports documented the emergence of linezolid-resistant VRE isolates (Bourgeois-Nicolaos et al. 2007; Saager et al. 2008) . Multidrugresistant enterococci pose a significant threat to public health. Increasing numbers of linezolid-resistant isolates have been detected worldwide. Therapy options are often limited for these isolates.
The need for new antibiotics to treat the increasing number of multidrug-resistant bacteria has recently been widely recognized. A novel oxazolidinone, tedizolid, was approved in June 2014 by the US Food and Drug Administration for the management of acute bacterial skin infections and skin structure infections in adults (Locke et al. 2014; Moellering 2014; Rybak and Roberts 2015) . This second-generation oxazolidinone has the advantage of being active against a specific subset linezolid-resistant enterococci, i.e. expressing the plasmid-encoded chloramphenicol-florfenicol resistance (cfr) gene (Rybak and Roberts 2015; Barber et al. 2016) .
However, oxazolidinone non-sensitivity (including linezolid and/or tedizolid non-sensitivity) has been reported among enterococci in recent years (Klupp et al. 2016) . Despite this, there are no exhaustive reports about the characteristics of these strains. Enterococcus faecalis and E. faecium are the main clinical Enterococcus spp. in hospital. Therefore, in this study, we investigated the antimicrobial susceptibility of E. faecalis and E. faecium isolates obtained from patients at our hospital (2011-2016) . We discovered tedizolid-non-susceptible enterococcal strains although tedizolid has not been used in our hospital. We then characterized the tedizolid-resistance mechanisms and the correlation of in vitro tedizolid activity with MLSTs and virulence factor distribution.
MATERIALS AND METHODS

Bacterial isolates
A total of 289 non-duplicate E. faecalis isolates and 68 nonduplicate E. faecium isolates were obtained from patients at Shenzhen Nanshan Hospital, which is affiliated with Shenzhen University, Shenzhen, China, between 1 January 2011 and 30 June 2016. Bacterial strains isolated from patients were identified using a VITEK 2 system (Biomérieux, Marcy l'Etoile, France). Species-appropriate quality control strains were used to ensure laboratory standards, as directed by the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI 2016) . Enterococcus faecalis ATCC29212 and OG1RF (ATCC47077) were used as reference strains, which were purchased from the American Type Culture Collection (ATCC).
Antibiotic susceptibility testing
The susceptibilities of the isolates to clinically relevant antibiotics (ampicillin, erythromycin, ciprofloxacin, rifampicin, tetracycline, nitrofurantion, vancomycin and linezolid) were tested using the VITEK 2 system. The minimum inhibitory concentration (MIC) of ampicillin, vancomycin linezolid and tedizolid was tested using the broth macrodilution method according to CLSI guidelines. The MIC breakpoints were based on the 2016 CLSI guidelines. Susceptibility was interpreted by applying FDA breakpoints available for E. faecalis and E. faecium (tedizolid MIC ≤0.5 μg/ml indicating susceptibility).
DNA extraction and polymerase chain reaction for detection of resistance genes and virulence factors
The DNA from all the isolates was extracted and purified using a DNeasy Blood and Tissue Kit (MGI Tech Co., Ltd, Shenzhen, China) according to the manufacturer's protocol for Grampositive bacteria. All the microbial DNA served as template for polymerase chain reaction (PCR) assay were stored at -20
• C.
PCR was carried out to detect the following resistance genes (which were selected based on previous reports): (B) , erm(C), the domain V region of the 23S rRNA gene, cfr, cfr(B), as well as the ABC transporter optrA (Nishimoto et al. 2005; Saager et al. 2008; Chancey, Zähner and Stephens et al. 2012; Liu et al. 2012 Liu et al. , 2013 Ntokou et al. 2012; Cai et al. 2015; Deshpande et al. 2015; Wang et al. 2015) . Various virulence factor genes in the E. faecalis and E. faecium strains, including asa1, esp, gelE, cylA, hyl, efaA, ace and agg genes, were also selected to be amplified by PCR, based on published documents (Duprè et al. 2003; Vankerckhoven et al. 2004; Zheng et al. 2017a,b) . All primer sequences and corresponding references are listed in Tables S1-S4 (Supporting Information). PCR amplification was performed in a total volume of 50 μl, containing 2 x PCR Master Mix (TIANGEN BIOTECH Co., Ltd, Beijing, China), 0.5 mM of each primer and 1 μl template DNA. The cycling conditions were as follows: 94
• C for 5 min, followed by 35 cycles of 94 • C for 30s, 54
• C for 45 s and 72
• C for 60 s, and final extension at 72
• C for 7 min. Each set of PCR reactions included a no-template control and a positive control. The amplification products were analyzed by gel electrophoresis using 1.0% agarose gel.
Multilocus sequence typing
Multilocus sequence typing (MLST) was used to analyze the genotypes of the enterococci isolates. Anin-house script was developed to extract the sequences of MLST alleles from assembled contigs according to the reference method (Ruiz-Garbajosa et al. 2006) . Briefly, seven housekeeping genes (gdh, gyd, pstS, gki, aroE, xpt and yqiL for E. faecalis, and atpA, ddl, gdh, purK, gyd, pstS and adk for E. faecium) were PCR amplified and sequenced (Homan et al. 2002; Nallapareddy et al. 2002) . All primer sequences and corresponding references are listed in Tables S5 Table 1A . Percentage of isolated E. faecalis strains that exhibited sensitive rate (S) to various antimicrobial agents. 
Statistical analysis
The prevalence of antibiotic susceptibility among the enterococcal isolates is presented as the number (percentage). These prevalences were compared between groups using the chi-square test or Fisher's exact test. The tests were performed using the SPSS software (version 19.0, Chicago, IL, USA). P values < 0.05 were regarded as statistically significant.
RESULTS
In vitro antibiotic activity and MLST of the enterococcal isolates
A total of 289 non-duplicate E. faecalis isolates and 68 nonduplicate E. faecium isolates were collected from the affiliated hospital of Shenzhen University (Shenzhen Nanshan Hospital, Shenzhen, China), during 2011-2016. The specimen sources and types are reported in Figs S1 and S2 (Supporting Information). The E. faecalis isolates detected at our hospital were mainly distributed in surgical departments (57.4%), including the Department of Urology, which had the highest proportion (22.1%), followed by the Department of Hepatobiliary Surgery (10.7%), the Intensive Care Unit (ICU;10.7%) and so on. However, E. faecium isolates were most commonly detected in Pediatrics (50%), followed by the ICU (13.2%), Department of Urology (13.2%), Department of Hepatobiliary Surgery (10.3%), Department of Respiration (4.4%) and Obstetrics and Gynecology (2.9%). The sensitivity rates among E. faecalis and E. faecium strains to various antimicrobial agents are reported in Table 1A and B. Many of the isolates were resistant to one or more of the comparator compounds examined. The most prominent were erythromycin, rifampicin and tetracycline, which had resistance rates >50% among both E. faecalis and E. faecium isolates. The tedizolid-sensitivity rate of E. faecalis and E. faecium was 94.1% and 100%, respectively. Enterococcus faecalis strains were sensitive to ampicillin, nitrofurantion and vancomycin (with sensitivity rates >98%). Furthermore, almost all of the tedizolidnon-susceptible E. faecalis isolates were sensitive to ampicillin, nitrofurantion and vancomycin based on in vitro activity.
MLST was used to identify the molecular phenotype of the E. faecalis and E. faecium strains (Fig. S3A and C, Supporting Information). A total of 47 different STs were eventually identified, but 48 strains were not matched with STs in the E. faecalis MLST database. The predominant STs were ST16 and ST179, accounting for 29.1% (84 strains) and 24.9% (72 strains), respectively. Moreover, the proportion of ST16 was significantly higher than the proportion of ST179 among the tedizolid-non-susceptible E. faecalis strains (P < 0.05) (Fig S3B, Supporting Information) . The MLST classification of E. faecium was not obviously clustered, and the main STs was ST18, accounting for 14.7%, followed by ST78 (7.4%). On the other hand, we had not found any correlation between in vitro tedizolid activity and different MLSTs in E. faecium strains.
Characterization of tedizolid-resistance mechanism among enterococci
The most common resistance genes found in enterococci were related to resistance against macrolides (erm(B), erm(A)), Table2 
tetracyclines (tet(M), tet(L)) and oxazolidinone (optrA). The results indicated the high tedizolid sensitivity among E. faecalis strains with tet(M) (93.16%), tet(L) (89.86%) and erm(B)
(96.22%) resistance genes. However, the E. faecalis strains with erm(A) and optrA had low tedizolid-sensitivity rates, at 7.14% and 18.18%, respectively. Moreover, the proportion of strains with optrA among tedizolidnon-susceptible E. faecalis isolates was higher than that among tedizolid-susceptible isolates (P < 0.05) (Fig 1A) . The data indicated that tedizolid exhibited good in vitro activity against all of the E. faecium strains, including multidrugresistance E.
faecium carrying tet(M), tet(L), tet(U), erm(A), erm(B)
and erm(C) genes (Fig 1B) . Among the E. faecium strains, >50% harbored at least one of three antimicrobial-resistant genes including tet(M), tet(L) and erm(C). That is to say, a high rate of resistance to tetracycline and erythromycin in the enterococci strains included in this study can be explained by comparatively high rate of the resistance genes tet (M) 
, tet(L), erm(B) and erm(A) carrying in E. faecalis strains and tet(M), tet(L) and erm(C) in E. faecium strains.
Correlation of in vitro tedizolid activity with virulence factor distribution
The virulence factors detected in E. faecalis were asa1, gelE, cylA, esp, hyl, efaA, agg and ace. Of all the E. faecalis isolates, 226 (78.2%) were positive for asa1, 184 (63.7%) for gelE, 193 (66.8%) for cylA, 174 (60.2%) for esp, 86 (29.8%) for hyl, 283 (97.9%) for efaA, 95 (32.9%) for agg and 285 (98.6%) for ace. The positive rate of the gelE virulence gene among tedizolid-susceptible E. faecalis strains was significantly higher than that among tedizolid-nonsusceptible E. faecalis strains (P < 0.05). There were no significant differences in the proportions of the other virulence factors among tedizolid-susceptible or tedizolid-non-susceptible E. faecalis isolates (Fig. 2) . Moreover, there were no significant difference between the average frequency of the number of virulence genes in tedizolid-susceptible E. faecalis strains (5.309 ± 0.09157, N = 272) and that of the tedizolid-non-susceptible E. faecalis strains (4.824 ± 0.4475, N = 17) (P = 0.21). Of the 68 E. faecium isolates, 19 (27.9%) were positive for esp and 14 (20.6%) for hyl. The distribution of virulence genes in different tedizolid MICs was shown in Table 2 .
DISCUSSION
Enterococci are one of the major causes of infection in hospitals. They have the ability to acquire genes encoding antibiotic resistance combined with a natural resistance to various antimicrobial agents. In this study, we found that almost all the E. faecalis isolates had in vitro susceptibility to ampicillin, nitrofurantion, vancomycin and tedizolid. Although the frequency of VRE isolates was not as high as in European countries and the USA (Shi et al. 2010; O'Driscoll and Crank 2015) , the frequency of linezolid resistance among E. faecalis isolates was higher in our study than in these countries (Bourgeois-Nicolaos et al. 2014; Flamm et al. 2016) . It is also worth mentioning that all of the linezolid/tedizolid-non-susceptible E. faecalis detected in this study were sensitive to ampicillin, vancomycin and nitrofurantoin. We speculate that these three antibiotics may be more suitable for treatment of E. faecalis infections in our hospital, rather than the more expensive linezolid or tedizolid.
In our study, the predominant STs among the E. faecalis strains were ST16 and ST179, and the proportion of ST16 isolates was significantly higher than the proportion of ST179 isolates among the tedizolid-non-susceptible E. faecalis strains. nosocomial infection-related strains have a higher tedizolid MIC than community infection-related strains.
Compared to linezolid, tedizolid had a higher activity against E. faecalis, resulting in lower MICs than those of linezolid. However, the optrA-positive E. faecalis strains had a low tedizolidsensitivity rate, which is alarming . Mutations in domain V of 23S rRNA are the main tedizolid-resistance mechanism, and a mutation from A to T of nucleotide 2576 is the most frequent alteration among clinical enterococcal isolates, linezolid resistance has mainly been linked to the G2576T mutation (Arias and Murray 2008) . Furthermore, linezolid resistance has also been associated with plasmid-encoded cfr, cfr(B) and the ABC transporter optrA. In our study, the presence of optrApositive strains reflected the main mechanism of tedizolidnon-susceptibility. Klupp et al. (2016) reported that the G2576T mutation leads to resistant against both linezolid and tedizolid. However, we did not confirm this phenomenon. Previously, the optrA gene in E. faecium isolates (of human and animal origin) was shown to confer resistance to tedizolid ). In the current study, 11 of 17 tedizolid-non-susceptible E. faecalis isolates were found to be optrA-positive isolates. Therefore, we inferred that the presence of optrA was the main mechanism of tedizolid-non-susceptibility in our study.
Multidrug-resistant bacteria with hypervirulent virulence or carrying many virulence factors can often cause severe infections that are often difficult to treat, especially for hospitalacquired infection. Therefore, the carrying rate of multiple virulent factors (asa1, gelE, cylA, esp, hyl, efaA, agg and ace) in enterococci, especially for multidrug-resistant isolates, often arouse our concern in clinics (Baylan et al. 2011; Mete et al. 2017) . Our data indicated that, although the virulence determinants were present in different proportions among the E. faecalis and E. faecium isolates, no special distribution of multiple virulence genes (asa1, gelE, cylA, esp, hyl, efaA, agg and ace) in the tedizolidnon-susceptible E. faecalis strains was found compared with that in tedizolid-susceptible ones. However, the clinical significance of the high rate of gelE in tedizolid-non-susceptible E. faecalis needs to be further studied. The E. faecalis isolates carried multiple virulence genes such as asa1, gelE, cylA, esp, hyl, efaA, agg and ace, while the E. faecium isolates were devoid of several virulence genes, except for esp and hyl. Enterococcus spp. have efficient gene-transfer mechanisms, including conjugation involving sex-pheromone plasmids and conjugation transposon. The chance that virulence factors may be acquired by conjugation is very high. Previous adhesion experiments have clearly confirmed that E. faecalis is more virulent than E. faecium (Duprè et al. 2003) .
CONCLUSION
Multidrug-resistant enterococcal strains were common. Judicious use of tedizolid and the application of appropriate infection control measures should be ensured to preserve the activity of this valuable antibiotic. In conclusion, based on the increasing use of linezolid therapies, it is tempting to speculate that the spread of linezolid-non-susceptible isolates will increase. The second-generation oxazolidinone tedizolid did not exhibit a significant advantage against the isolates expressing the plasmidencoded optrA gene. As tedizolid has not been used in our hospital, further clinical studies are needed to analyze the effectiveness of tedizolid against enterococcal infections.
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